Henri Leinonen
Impact in
- Ophthalmology top 2%
- Retinal Diseases and Treatments
-
- Photoreceptor and optogenetics research
- Neuroscience and Neuropharmacology Research
Papers in
-
- Retinal Diseases and Treatments 12
-
- Neuroscience and Neuropharmacology Research 6
- Photoreceptor and optogenetics research 5
- Co-authors
- Krzysztof Palczewski (16 shared papers)Heikki Tanila (10 shared papers)Elliot H. Choi (7 shared papers)Susie Suh (4 shared papers)Zhiqian Dong (4 shared papers)Philip D. Kiser (5 shared papers)David C. Lyon (3 shared papers)Andrzej T. Foik (3 shared papers)
- Journals
- Investigative Ophthalmology & Visual Science (3 papers)JCI Insight (2 papers)Journal of Pharmacology and Experimental Therapeutics (2 papers)Redox Biology (2 papers)Nature Communications (2 papers)
- Partner nations
- United StatesFinlandPoland
In The Last Decade
Henri Leinonen
34 papers receiving 997 citations
Henri Leinonen's Hit Papers
Peers
Comparison fields: 5 of 83
- Ophthalmology 233
- Cellular and Molecular Neuroscience 210
- Molecular Biology 646
- Neurology 59
- Cell Biology 82
Countries citing papers authored by Henri Leinonen
This map shows the geographic impact of Henri Leinonen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henri Leinonen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henri Leinonen more than expected).
Fields of papers citing papers by Henri Leinonen
This network shows the impact of papers produced by Henri Leinonen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henri Leinonen. The network helps show where Henri Leinonen may publish in the future.
Co-authors
The 25 scholars most cited alongside Henri Leinonen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 139 | |
| 2 | 2020 | 131 | |
| 3 | 2022 | 71 | |
| 4 | 2020 | 55 | |
| 5 | 2019 | 54 | |
| 6 | 2017 | 50 | |
| 7 | 2017 | 48 | |
| 8 | 2020 | 43 | |
| 9 | Computational drug repurposing: approaches, evaluation of in silico resources and case studies Hit paper breakdown → | 2025 | 40 |
| 10 | 2014 | 37 | |
| 11 | 2016 | 36 | |
| 12 | 2016 | 31 | |
| 13 | 2021 | 30 | |
| 14 | 2022 | 30 | |
| 15 | 2017 | 20 | |
| 16 | 2021 | 19 | |
| 17 | 2016 | 19 | |
| 18 | 2016 | 18 | |
| 19 | 2022 | 16 | |
| 20 | 2022 | 15 |
About Henri Leinonen
Henri Leinonen is a scholar working on Ophthalmology, Cellular and Molecular Neuroscience, Molecular Biology, Endocrine and Autonomic Systems and Cancer Research, having authored 37 papers that have together received 1.0k indexed citations. Recurring topics across this work include Retinal Development and Disorders (19 papers), Retinal Diseases and Treatments (12 papers), Neuroscience and Neuropharmacology Research (6 papers), Photoreceptor and optogenetics research (5 papers), Retinoids in leukemia and cellular processes (3 papers), Circadian rhythm and melatonin (3 papers), Receptor Mechanisms and Signaling (3 papers) and Cancer, Hypoxia, and Metabolism (3 papers). The work is most often cited by research in Ophthalmology (233 citations), Cellular and Molecular Neuroscience (210 citations), Molecular Biology (646 citations), Neurology (59 citations) and Cell Biology (82 citations). Henri Leinonen has collaborated with scholars based in United States, Finland and Poland. Frequent co-authors include Krzysztof Palczewski, Heikki Tanila, Elliot H. Choi, Susie Suh, Zhiqian Dong, Philip D. Kiser, David C. Lyon, Andrzej T. Foik, David R. Liu and Gregory A. Newby. Their work appears in journals such as Investigative Ophthalmology & Visual Science, JCI Insight, Journal of Pharmacology and Experimental Therapeutics, Redox Biology and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.